GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Neurocrine Biosciences Inc (FRA:NB3) » Definitions » Beginning Cash Position

Neurocrine Biosciences (FRA:NB3) Beginning Cash Position : €238 Mil (As of Mar. 2024)


View and export this data going back to 1996. Start your Free Trial

What is Neurocrine Biosciences Beginning Cash Position?

Neurocrine Biosciences's Beginning Cash Position for the quarter that ended in Mar. 2024 was €238 Mil.

Neurocrine Biosciences's quarterly Beginning Cash Position increased from Sep. 2023 (€158 Mil) to Dec. 2023 (€277 Mil) but then declined from Dec. 2023 (€277 Mil) to Mar. 2024 (€238 Mil).

Neurocrine Biosciences's annual Beginning Cash Position increased from Dec. 2021 (€168 Mil) to Dec. 2022 (€325 Mil) but then declined from Dec. 2022 (€325 Mil) to Dec. 2023 (€248 Mil).

Neurocrine Biosciences Beginning Cash Position Historical Data

The historical data trend for Neurocrine Biosciences's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Neurocrine Biosciences Beginning Cash Position Chart

Neurocrine Biosciences Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Beginning Cash Position
Get a 7-Day Free Trial Premium Member Only Premium Member Only 132.48 94.94 168.42 324.74 248.23

Neurocrine Biosciences Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Beginning Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 252.83 103.01 157.60 276.94 238.37

Neurocrine Biosciences Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

Neurocrine Biosciences Beginning Cash Position Related Terms

Thank you for viewing the detailed overview of Neurocrine Biosciences's Beginning Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Neurocrine Biosciences (FRA:NB3) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Neurocrine Biosciences Inc (FRA:NB3) » Definitions » Beginning Cash Position
Comparable Companies
VTRS CTLT ITCI ELAN LNTH PRGO ALKS ALVO PBH AMPH ZTS XTER:MRK NSE:SUNPHARMA TSE:4502 LSE:HLN XTAE:TEVA XSWX:SDZ SZSE:000538 HKSE:03692 TSE:4507
Traded in Other Exchanges
NBIX:USA N1BI34:Brazil
Address
12780 El Camino Real, San Diego, CA, USA, 92130
Website
https://www.neurocrine.com
Neurocrine Biosciences Inc is a research-based pharmaceutical company advancing drug candidates in the central nervous system and endocrine-related categories. The company's three late stage clinical programs are elagolix which is hormone releasing antagonist for women's health, opicapone which is an inhibitor for parkinson's patients, and ingrezza for tourette syndrome.

Neurocrine Biosciences (FRA:NB3) Headlines

No Headlines